|1||NCT03285620||Recruiting||A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Subjects||
||81||All||18 Years to 55 Years (Adult)||NCT03285620||AL-034-1201||September 7, 2017||June 30, 2020||June 30, 2020||September 18, 2017||November 6, 2017||
|2||NCT00226382||Completed||Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment||
||Other / Industry||
||50||All||18 Years to 70 Years (Adult, Senior)||NCT00226382||Pegasys Study||January 2005||April 2008||April 2008||September 27, 2005||June 11, 2010||
† Study has passed its completion date and status has not been verified in more than two years.